helen darling, who runs the national business group on .ealth ron williams, former ceo of aetna. raymond gilmartin, former ceo of merck. you have their bios in your packet. i urge you to read them and be impressed, but we will dive right into the questioning here. what i'd like to do, angela, art with you. at the end of the day, there are only three things that matter here. access to care, the cost of care , and the quality of the care. so what i'd like to do is get the panel to talk a little bit about how the affordable care act, given what we know today, seems to be doing on each of those measures. i'd like you to start with access. >> i think access was ultimately the goal, when you think about the provisions in the affordable care act that related to cost and quality. they are either not there or not in place at this point. so we really have not seen the impact of that. you are right, there has been so much heat and smoke about execution, implementation, that it is hard to see where we are, but we have good data now. you probably have all the numbers in terms of additional access. th